MANGOCEUTICALS INC(NASDAQ:MGRX) stock News

MGRX Latest News, Press Relases and Analysis

All

Press Releases

24 days ago - By: Benzinga - Mentions: MSS UNFI XXII IMG ...

12 Consumer Staples Stocks Moving In Thursday's After-Market Session

2 months ago - By: Mangoceuticals, Inc.

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

4 months ago - By: Mangoceuticals, Inc.

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

4 months ago - By: ACCESS Newswire

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions

10 months ago - By: Benzinga - Mentions: COTY XXII

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter

a year ago - By: InvestorPlace

MGRX Stock Earnings: Mangoceuticals Reported Results for Q2 2024

4 months ago - By: ACCESS Newswire

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

a year ago - By: Mangoceuticals, Inc.

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

5 months ago - By: Mangoceuticals, Inc.

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

6 months ago - By: Mangoceuticals, Inc.

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

6 months ago - By: Mangoceuticals, Inc.

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

8 months ago - By: Mangoceuticals, Inc.

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

8 months ago - By: Mangoceuticals, Inc.

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

10 months ago - By: Mangoceuticals, Inc.

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

10 months ago - By: Mangoceuticals, Inc.

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

10 months ago - By: Mangoceuticals, Inc.

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

10 months ago - By: Mangoceuticals, Inc.

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

a year ago - By: Mangoceuticals, Inc.

MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

a year ago - By: Mangoceuticals, Inc.

MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent

a year ago - By: Mangoceuticals, Inc.

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

a year ago - By: Mangoceuticals, Inc.

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

a year ago - By: Mangoceuticals, Inc.

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

a year ago - By: Mangoceuticals, Inc.

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

a year ago - By: Mangoceuticals, Inc.

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

a year ago - By: Mangoceuticals, Inc.

MANGOCEUTICALS INC (MGRX) Stock News

MGRX Latest News, Press Relases and Analysis

12 Consumer Staples Stocks Moving In Thursday's After-Market Session

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter

MGRX Stock Earnings: Mangoceuticals Reported Results for Q2 2024

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology